Shabirul et al. designed exosomes to express CD19 chimeric antigen receptors, enabling them to target CD19-positive leukemia B cells through receptor-ligand interactions and induce cell death without affecting CD19-negative cells (Pakharukova et al., 2023). This evidence concerns the gene CD19 and leukemia.